2,801
Views
18
CrossRef citations to date
0
Altmetric
Clinical Study

Screening Fabry’s disease in chronic kidney disease patients not on dialysis: a multicenter study

, , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 104-111 | Received 27 May 2016, Accepted 25 Oct 2016, Published online: 10 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ruixiao Zhang, Zeqing Chen, Yanhua Lang, Shihong Shao, Yan Cai, Qingqing You, Yan Sun, Sai Wang, Xiaomeng Shi, Zhiying Liu, Wencong Guo, Yue Han & Leping Shao. (2020) Sudden onset of nephrotic syndrome in an asymptomatic Fabry patient: a case report. Renal Failure 42:1, pages 958-965.
Read now

Articles from other publishers (17)

Daniel Linares, Beatriz Luna, Edson Loayza, Gonzalo Taboada & Uma Ramaswami. (2023) Prevalence of Fabry disease in patients with chronic kidney disease: A systematic review and meta-analysis. Molecular Genetics and Metabolism 140:4, pages 107714.
Crossref
Saadet SAYAN, Dilcan KOTAN, Esen ÇİÇEKLİ & Murat ALEMDAR. (2023) The Frequency of Fabry Disease in Acute Stroke Patients with Renal Insufficiency in Sakarya ProvinceSakarya İli Akut İskemik İnme ve Kronik Renal Yetmezlikli Olgularda Fabry Hastalığı Sıklığı. Düzce Tıp Fakültesi Dergisi.
Crossref
Rita Vicente, Iolanda Santos, Miguel Coimbra, Joana Santos, Ricardo Santos, Manuel Amoedo & Carlos Pires. (2023) D313Y variant in two related end-stage renal disease patients – Pathogenic or not yet?. Nefrología (English Edition) 43:5, pages 636-639.
Crossref
Rita Vicente, Iolanda Santos, Miguel Coimbra, Joana Santos, Ricardo Santos, Manuel Amoedo & Carlos Pires. (2023) D313Y variant in two related end-stage renal disease patients – Pathogenic or not yet?. Nefrología 43:5, pages 636-639.
Crossref
Özdem Kavraz Tomar, Ayşe Zeynep Bal, Semahat Karahisar Şirali, Murat Duranay, Berfu Korucu, Galip Güz & Seyit İbrahim Akdağ. (2023) The prevalence of Fabry disease in a Turkish population with chronic kidney patients. International Urology and Nephrology 55:6, pages 1629-1634.
Crossref
Andrew Mallett, Phoebe Jane Kearey, Anne Cameron, Helen G. Healy, Charles Denaro, Mark Thomas, Vincent W. Lee, Samantha Louise Stark, Maria Fuller, Zaimin Wang & Wendy E. Hoy. (2022) The prevalence of Fabry disease in a statewide chronic kidney disease cohort – Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study. BMC Nephrology 23:1.
Crossref
Lina PalaiodimouMaria-Ioanna StefanouEleni BakolaMarianna PapadopoulouPanagiotis KokotisAgathi-Rosa VrettouEleni KapsiaDimitrios PetrasAris AnastasakisNikolaos XifarasEleni KarachaliouGiota TouloumiCharalambos VlachopoulosIoannis N. BoletisSotirios Giannopoulos, Georgios TsivgoulisChristina Zompola. (2022) D313Y Variant in Fabry Disease . Neurology 99:19.
Crossref
Takaaki Sawada, Jun Kido, Keishin Sugawara & Kimitoshi Nakamura. (2021) High-Risk Screening for Fabry Disease: A Nationwide Study in Japan and Literature Review. Diagnostics 11:10, pages 1779.
Crossref
Luciana Senra de Souza Sodré, Rosália Maria Nunes Henriques Huaira, Fernando Antônio Basile Colugnati, Moises Carminatti, Luciane Senra de Souza Braga, Marcelo Paula Coutinho & Natália Maria da Silva Fernandes. (2021) Screening of family members of chronic kidney disease patients with Fabry disease mutations: a very important and underrated task. Brazilian Journal of Nephrology 43:1, pages 28-33.
Crossref
Ozlem Sezer & Serdar Ceylaner. (2021) Genetic Management Algorithm in High-Risk Fabry Disease Cases; Especially in Female Indexes with Mutations. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:2, pages 324-337.
Crossref
Yuri Battaglia, Fulvio Fiorini, Cristiano Azzini, Pasquale Esposito, Alessandro De vito, Antonio Granata, Alda Storari & Renzo Mignani. (2021) Deficiency in the Screening Process of Fabry Disease: Analysis of Chronic Kidney Patients Not on Dialysis. Frontiers in Medicine 8.
Crossref
Andrew Mallett, Phoebe Kearey, Anne Cameron, Helen Healy, Charles Denaro, Mark Thomas, Vincent W. Lee, Samantha Stark, Maria Fuller & Wendy E. Hoy. (2020) The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia. BMC Nephrology 21:1.
Crossref
Sheela Nampoothiri, Dhanya Yesodharan, Amrita Bhattacherjee, Hisham Ahamed, Ratna Dua Puri, Neerja Gupta, Madhulika Kabra, Prajnya Ranganath, Meenakshi Bhat, Shubha Phadke, Akella Radha Rama Devi, Sujatha Jagadeesh, Sumita Danda, Padmavathy Narayana Sylaja, Kausik Mandal, Sunita Bijarnia‐Mahay, Ravinder Makkar, Ishwar Chander Verma, Ashwin Dalal & Uma Ramaswami. (2020) Fabry disease in India: A multicenter study of the clinical and mutation spectrum in 54 patients. JIMD Reports 56:1, pages 82-94.
Crossref
Grigoris Effraimidis, Åse K. Rasmussen, Henning Bundgaard, Søren S. Sørensen & Ulla Feldt‐Rasmussen. (2020) Is the alpha‐galactosidase A variant p.Asp313Tyr ( p.D313Y ) pathogenic for Fabry disease? A systematic review . Journal of Inherited Metabolic Disease 43:5, pages 922-933.
Crossref
Siyar Erdogmus, Sim Kutlay, Gizem Kumru, Damla Ors Sendogan, Sehsuvar Erturk, Kenan Keven, Gulay Ceylaner & Sule Sengul. (2020) Fabry Disease Screening in Patients With Kidney Transplant: A Single-Center Study in Turkey. Experimental and Clinical Transplantation 18:4, pages 444-449.
Crossref
Christiane Auray-Blais, Pamela Lavoie, Mona Abaoui, Anne-Marie Côté, Michel Boutin, Ayub Akbari, Adeera Levin, Fabrice Mac-Way & Joe TR Clarke. (2020) High-risk screening for Fabry disease in a Canadian cohort of chronic kidney disease patients. Clinica Chimica Acta 501, pages 234-240.
Crossref
Joaquín Frabasil, Consuelo Durand, Silvia Sokn, Daniela Gaggioli, Patricia Carozza, Ricardo Carabajal, Juan Politei & Andrea B. Schenone. (2019) Prevalence of Fabry disease in male dialysis patients: Argentinean screening study. JIMD Reports 48:1, pages 45-52.
Crossref